Close Menu

Cancer in His Sights

In a series, the New York Times profiles the work of Keith Flaherty, an oncologist at the University of Pennsylvania, who has evangelized a targeted approach to treating cancer. The first part follows the highs and lows of clinical trials after Flaherty jumped headlong into testing drugs targeting B-RAF mutations in cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.